Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.490
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
1.500
+0.010 (0.67%)
After-hours: May 12, 2025, 7:38 PM EDT
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $9.41 million as of May 12, 2025. Its market cap has decreased by -56.30% in one year.
Market Cap
9.41M
Enterprise Value
13.56M
1-Year Change
-56.30%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $9.41M, a decrease of -95.10%. That is a compound annual growth rate of -50.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 9.41M | 89.78% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |